JB Chemicals & Pharmaceuticals PAT at Rs. 118.9 cr for Q1 FY22

Domestic formulations business records 39 % growth while the international business revenue was largely flat as compared to Q1 FY21

JB Chemicals PAT jumps by 101% to Rs101 Cr

The company recorded revenue of Rs 528crore as compared to Rs 444 crore, registering a growth of 19% over the corresponding quarter ended 31st March 2020

Aarti Speciality Chemicals receives PLI approval for pharmaceutical sector

The company received approval for 2-Methyl-5Nitro-Imidazole (2-MNI) with a committed production capacity of 4,000 MT per annum.

J B Chemicals & Pharmaceuticals Q3FY 21 consolidated PAT up at Rs. 151.66 Cr

The company posted net profit of Rs.62.17 crores for the period ended December 31, 2019.

JB Pharma Q1 FY26 PAT up at 14% to Rs. 202 Cr

Jubilant Ingrevia Q1 FY26 YoY net profit jumps 54% to Rs. 75 Cr

Our specialty chemical businesses have continued to perform strongly, growing double digit YoY

Bio-Rad names Rajat Mehta as EVP - Global Commercial Operations

Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics

Cohance Lifesciences appoints Yann D'Herve as CEO of CDMO Business

His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors

Dr. Reddy’s re-appoints G V Prasad as Co-Chairman and Managing Director

Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation

Granules India CEO K V Sitaram Rao resigns

Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service